AngioDynamics (ANGO) Bolsters Senior Leadership Team With Key Appointments
9/28/2012 10:23:56 AM
ALBANY, N.Y., Sept. 27, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of Louis J. Mazzarese, Senior Vice President and Chief Regulatory Officer, effective October 3, 2012, and John Soto, Senior Vice President, Global Franchise, Peripheral Vascular, effective immediately. Mr. Mazzarese and Mr. Soto will report to President and CEO Joseph M. DeVivo.
comments powered by